Literature DB >> 17613199

Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components.

Daniel M Sciubba1, Li-Mei Lin, Graeme F Woodworth, Matthew J McGirt, Benjamin Carson, George I Jallo.   

Abstract

OBJECT: Antibiotic-impregnated shunt (AIS) systems may decrease the incidence of cerebrospinal fluid (CSF) shunt infections. However, there is a reluctance to use AIS components because of their increased cost. In the present study the authors evaluated factors contributing to the medical costs associated with the treatment of CSF shunt infections in a hydrocephalic pediatric population, those implanted with AIS systems compared with those implanted with standard shunt systems.
METHODS: The authors retrospectively reviewed data obtained in all pediatric patients who had undergone CSF shunt insertion at their institution over a 3-year period. All patients were followed up for 12 months after surgery. The independent association between AIS catheter use and subsequent shunt infection was assessed by performing a multivariate proportional hazards regression analysis. Factors contributing to the medical costs associated with shunt infection were evaluated.
RESULTS: Two hundred eleven pediatric patients underwent 353 shunting procedures. Two hundred eight shunts (59%) were placed with nonimpregnated catheters and 145 shunts (41%) were placed with AIS catheters. Twenty-five patients (12%) with non-AIS catheters experienced shunt infection, whereas only two patients (1.4%) with AIS catheters had a shunt infection within the 6-month follow-up period (p < 0.01). Among infected patients, infected patients with standard shunt components had a longer average hospital stay, more inpatient complications related to infection treatment, and more multiple organism infections and multiple antibiotic regimens, compared with those with AIS components.
CONCLUSIONS: Although individual AIS components are more expensive than standard ones, factors contributing to medical costs are fewer in pediatric patients with infected shunts when the components are antibiotic-impregnated rather than standard.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613199     DOI: 10.3171/foc.2007.22.4.11

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  11 in total

1.  The economic impact of ventriculoperitoneal shunt failure.

Authors:  Chevis N Shannon; Tamara D Simon; Gavin T Reed; Frank A Franklin; Russell S Kirby; Meredith L Kilgore; John C Wellons
Journal:  J Neurosurg Pediatr       Date:  2011-12       Impact factor: 2.375

2.  Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.

Authors:  Sebastian Hhmj Arts; Hieronymus Damianus Boogaarts; Erik J van Lindert
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04

3.  Activity of an antimicrobial hydrocephalus shunt catheter against Propionibacterium acnes.

Authors:  Roger Bayston; Litza Vera; Waheed Ashraf
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

4.  Antibiotic-impregnated ventriculoperitoneal shunts--a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls.

Authors:  Jothy Kandasamy; Kerry Dwan; John C Hartley; Michael D Jenkinson; Caroline Hayhurst; Sylvia Gatscher; Dominic Thompson; Darach Crimmins; Conor Mallucci
Journal:  Childs Nerv Syst       Date:  2010-10-17       Impact factor: 1.475

5.  Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting.

Authors:  R M Ahmed; F Zmudzki; G D Parker; B K Owler; G M Halmagyi
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-28       Impact factor: 3.825

6.  Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.

Authors:  Raquel Gutiérrez-González; Gregorio R Boto; Cristina Fernández-Pérez; Náyade del Prado
Journal:  BMC Neurol       Date:  2010-10-12       Impact factor: 2.474

7.  Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro.

Authors:  L N Pettingill; R L Minter; R K Shepherd
Journal:  Neuroscience       Date:  2008-01-01       Impact factor: 3.590

8.  The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol.

Authors:  Michael D Jenkinson; Carrol Gamble; John C Hartley; Helen Hickey; Dyfrig Hughes; Michaela Blundell; Michael J Griffiths; Tom Solomon; Conor L Mallucci
Journal:  Trials       Date:  2014-01-03       Impact factor: 2.279

9.  Neutrophil CD64 index in cerebrospinal fluid as a marker of bacterial ventriculitis in children with external ventricular drainage.

Authors:  Mojca Groselj-Grenc; Metka Derganc; Andreja Natasa Kopitar; Maja Pavcnik
Journal:  BMC Pediatr       Date:  2019-04-25       Impact factor: 2.125

10.  Ventriculo-peritoneal shunting devices for hydrocephalus.

Authors:  Luis Garegnani; Juan Va Franco; Agustín Ciapponi; Virginia Garrote; Valeria Vietto; Santiago Adalberto Portillo Medina
Journal:  Cochrane Database Syst Rev       Date:  2020-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.